Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

ASNC Fighting Back Against Proposed Reimbursement Cuts for Amyloid Imaging

News Daily News

ASNC Fighting Back Against Proposed Reimbursement Cuts for Amyloid Imaging

Yael L. Maxwell

September 11, 2025

Acoramidis Approved in Europe for ATTR Cardiomyopathy

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

News Daily News

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

Yael L. Maxwell

December 12, 2024

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

November 25, 2024

ATTRibute-CM Top-Line Results Favorable for Acoramidis in Transthyretin Amyloidosis

News Daily News

ATTRibute-CM Top-Line Results Favorable for Acoramidis

July 17, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

January 31, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Features

Year in Review: Physicians Pick the Biggest News of 2018

TCTMD News Team

December 29, 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

September 14, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.